1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Ortho Alexis

Discussion in 'Applied Medical' started by Anonymous, Jun 6, 2014 at 10:29 PM.

  1. anonymous

    anonymous Guest

    After a successful case- have the scrub tech update the preference card- they are the ones that get chewed out if they don't have the correct product open and available on the back table. A nurse manager thinks updating preference cards are time consuming and low on their priority list
     
  2. anonymous

    anonymous Guest

    Why don't you stop making excuse or stop being scared to talk to a doc?